Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide Andrew J. KrentzKen FujiokaMarcus Hompesch Editorial 12 May 2015 Pages: 931 - 933
The New Era of Drug Therapy for Obesity: The Evidence and the Expectations Ben J. JonesStephen R. Bloom Leading Article Open access 19 May 2015 Pages: 935 - 945
Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis Heinz WiendlSven G. Meuth Leading Article Open access 02 June 2015 Pages: 947 - 977
Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice Julie KalabalikGail B. RattingerAnastasia Rivkin Review Article 22 May 2015 Pages: 979 - 998
Management Strategies for Clopidogrel Hypersensitivity Craig J. BeaversNicolas W. CarrisKathryn M. Ruf Review Article 09 June 2015 Pages: 999 - 1007
Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours Matt ShirleyGillian M. Keating Adis Drug Evaluation 22 May 2015 Pages: 1009 - 1017
Extended-Cycle Levonorgestrel/Ethinylestradiol and Low-Dose Ethinylestradiol (Seasonique®): A Review of Its Use as an Oral Contraceptive Celeste B. Burness Adis Drug Evaluation 28 May 2015 Pages: 1019 - 1026
Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir: A Review in Chronic HCV Genotype 1 Infection Emma D. Deeks Adis Drug Evaluation 10 June 2015 Pages: 1027 - 1038